
Coronary Artery Bypass Grafts (CABG) Industry Research Report 2024
Description
Coronary Artery Bypass Grafts (CABG) Industry Research Report 2024
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Highlights
The global Coronary Artery Bypass Grafts (CABG) market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Coronary Artery Bypass Grafts (CABG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Artery Bypass Grafts (CABG).
The Coronary Artery Bypass Grafts (CABG) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coronary Artery Bypass Grafts (CABG) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronary Artery Bypass Grafts (CABG) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH
Product Type Insights
Global markets are presented by Coronary Artery Bypass Grafts (CABG) type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Coronary Artery Bypass Grafts (CABG) are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Coronary Artery Bypass Grafts (CABG) segment by Type
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Coronary Artery Bypass Grafts (CABG) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Coronary Artery Bypass Grafts (CABG) market.
Coronary Artery Bypass Grafts (CABG) Segment by Application
Traditional CABG
Nontraditional CABG
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Coronary Artery Bypass Grafts (CABG) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Artery Bypass Grafts (CABG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Coronary Artery Bypass Grafts (CABG) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Coronary Artery Bypass Grafts (CABG) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Artery Bypass Grafts (CABG).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Coronary Artery Bypass Grafts (CABG) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
86 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Coronary Artery Bypass Grafts (CABG) by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 1.2.2 Saphenous Vein Grafts
- 1.2.3 Internal Thoracic Artery Grafts
- 1.2.4 Other
- 2.3 Coronary Artery Bypass Grafts (CABG) by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Traditional CABG
- 2.3.3 Nontraditional CABG
- 2.4 Assumptions and Limitations
- 3 Coronary Artery Bypass Grafts (CABG) Breakdown Data by Type
- 3.1 Global Coronary Artery Bypass Grafts (CABG) Historic Market Size by Type (2019-2024)
- 3.2 Global Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Type (2025-2030)
- 4 Coronary Artery Bypass Grafts (CABG) Breakdown Data by Application
- 4.1 Global Coronary Artery Bypass Grafts (CABG) Historic Market Size by Application (2019-2024)
- 4.2 Global Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global Coronary Artery Bypass Grafts (CABG) Market Perspective (2019-2030)
- 5.2 Global Coronary Artery Bypass Grafts (CABG) Growth Trends by Region
- 5.2.1 Global Coronary Artery Bypass Grafts (CABG) Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 Coronary Artery Bypass Grafts (CABG) Historic Market Size by Region (2019-2024)
- 5.2.3 Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Region (2025-2030)
- 5.3 Coronary Artery Bypass Grafts (CABG) Market Dynamics
- 5.3.1 Coronary Artery Bypass Grafts (CABG) Industry Trends
- 5.3.2 Coronary Artery Bypass Grafts (CABG) Market Drivers
- 5.3.3 Coronary Artery Bypass Grafts (CABG) Market Challenges
- 5.3.4 Coronary Artery Bypass Grafts (CABG) Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Coronary Artery Bypass Grafts (CABG) Players by Revenue
- 6.1.1 Global Top Coronary Artery Bypass Grafts (CABG) Players by Revenue (2019-2024)
- 6.1.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Players (2019-2024)
- 6.2 Global Coronary Artery Bypass Grafts (CABG) Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of Coronary Artery Bypass Grafts (CABG) Head office and Area Served
- 6.4 Global Coronary Artery Bypass Grafts (CABG) Players, Product Type & Application
- 6.5 Global Coronary Artery Bypass Grafts (CABG) Players, Date of Enter into This Industry
- 6.6 Global Coronary Artery Bypass Grafts (CABG) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Coronary Artery Bypass Grafts (CABG) Market Size (2019-2030)
- 7.2 North America Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024)
- 7.4 North America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Coronary Artery Bypass Grafts (CABG) Market Size (2019-2030)
- 8.2 Europe Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024)
- 8.4 Europe Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size (2019-2030)
- 9.2 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024)
- 9.4 Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
- 10 Latin America
- 10.1 Latin America Coronary Artery Bypass Grafts (CABG) Market Size (2019-2030)
- 10.2 Latin America Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024)
- 10.4 Latin America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030)
- 9.4 Mexico
- 9.5 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size (2019-2030)
- 11.2 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024)
- 11.4 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
- 12 Players Profiled
- 11.1 Medtronic
- 11.1.1 Medtronic Company Detail
- 11.1.2 Medtronic Business Overview
- 11.1.3 Medtronic Coronary Artery Bypass Grafts (CABG) Introduction
- 11.1.4 Medtronic Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.1.5 Medtronic Recent Development
- 11.2 Getinge Group
- 11.2.1 Getinge Group Company Detail
- 11.2.2 Getinge Group Business Overview
- 11.2.3 Getinge Group Coronary Artery Bypass Grafts (CABG) Introduction
- 11.2.4 Getinge Group Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.2.5 Getinge Group Recent Development
- 11.3 LivaNova
- 11.3.1 LivaNova Company Detail
- 11.3.2 LivaNova Business Overview
- 11.3.3 LivaNova Coronary Artery Bypass Grafts (CABG) Introduction
- 11.3.4 LivaNova Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.3.5 LivaNova Recent Development
- 11.4 Terumo
- 11.4.1 Terumo Company Detail
- 11.4.2 Terumo Business Overview
- 11.4.3 Terumo Coronary Artery Bypass Grafts (CABG) Introduction
- 11.4.4 Terumo Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.4.5 Terumo Recent Development
- 11.5 Boston Scientific
- 11.5.1 Boston Scientific Company Detail
- 11.5.2 Boston Scientific Business Overview
- 11.5.3 Boston Scientific Coronary Artery Bypass Grafts (CABG) Introduction
- 11.5.4 Boston Scientific Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.5.5 Boston Scientific Recent Development
- 11.6 Stryker
- 11.6.1 Stryker Company Detail
- 11.6.2 Stryker Business Overview
- 11.6.3 Stryker Coronary Artery Bypass Grafts (CABG) Introduction
- 11.6.4 Stryker Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.6.5 Stryker Recent Development
- 11.7 Edwards Lifesciences
- 11.7.1 Edwards Lifesciences Company Detail
- 11.7.2 Edwards Lifesciences Business Overview
- 11.7.3 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Introduction
- 11.7.4 Edwards Lifesciences Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.7.5 Edwards Lifesciences Recent Development
- 11.8 Genesee Biomedical
- 11.8.1 Genesee Biomedical Company Detail
- 11.8.2 Genesee Biomedical Business Overview
- 11.8.3 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Introduction
- 11.8.4 Genesee Biomedical Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.8.5 Genesee Biomedical Recent Development
- 11.9 Karl Storz GmbH
- 11.9.1 Karl Storz GmbH Company Detail
- 11.9.2 Karl Storz GmbH Business Overview
- 11.9.3 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Introduction
- 11.9.4 Karl Storz GmbH Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022)
- 11.9.5 Karl Storz GmbH Recent Development
- 13 Report Conclusion
- 14 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
- Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
- Table 5. Global Coronary Artery Bypass Grafts (CABG) Market Size by Type (2019-2024) & (US$ Million)
- Table 6. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2019-2024)
- Table 7. Global Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Type (2025-2030) & (US$ Million)
- Table 8. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2025-2030)
- Table 9. Global Coronary Artery Bypass Grafts (CABG) Market Size by Application (2019-2024) & (US$ Million)
- Table 10. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2019-2024)
- Table 11. Global Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Application (2025-2030) & (US$ Million)
- Table 12. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2025-2030)
- Table 13. Global Coronary Artery Bypass Grafts (CABG) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
- Table 14. Global Coronary Artery Bypass Grafts (CABG) Market Size by Region (2019-2024) & (US$ Million)
- Table 15. Global Coronary Artery Bypass Grafts (CABG) Market Share by Region (2019-2024)
- Table 16. Global Coronary Artery Bypass Grafts (CABG) Forecasted Market Size by Region (2025-2030) & (US$ Million)
- Table 17. Global Coronary Artery Bypass Grafts (CABG) Market Share by Region (2025-2030)
- Table 18. Coronary Artery Bypass Grafts (CABG) Market Trends
- Table 19. Coronary Artery Bypass Grafts (CABG) Market Drivers
- Table 20. Coronary Artery Bypass Grafts (CABG) Market Challenges
- Table 21. Coronary Artery Bypass Grafts (CABG) Market Restraints
- Table 22. Global Top Coronary Artery Bypass Grafts (CABG) Manufacturers by Revenue (US$ Million) & (2019-2024)
- Table 23. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Manufacturers (2019-2024)
- Table 24. Global Coronary Artery Bypass Grafts (CABG) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
- Table 25. Global Key Players of Coronary Artery Bypass Grafts (CABG), Headquarters and Area Served
- Table 26. Global Coronary Artery Bypass Grafts (CABG) Manufacturers, Product Type & Application
- Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 28. Global Coronary Artery Bypass Grafts (CABG) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
- Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
- Table 30. North America Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 31. North America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024) & (US$ Million)
- Table 32. North America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030) & (US$ Million)
- Table 33. Europe Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 34. Europe Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024) & (US$ Million)
- Table 35. Europe Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030) & (US$ Million)
- Table 36. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 37. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024) & (US$ Million)
- Table 38. Asia-Pacific Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030) & (US$ Million)
- Table 39. Latin America Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 40. Latin America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024) & (US$ Million)
- Table 41. Latin America Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030) & (US$ Million)
- Table 42. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
- Table 43. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size by Country (2019-2024) & (US$ Million)
- Table 44. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Market Size by Country (2025-2030) & (US$ Million)
- Table 45. Medtronic Company Detail
- Table 46. Medtronic Business Overview
- Table 47. Medtronic Coronary Artery Bypass Grafts (CABG) Product
- Table 48. Medtronic Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 49. Medtronic Recent Development
- Table 50. Getinge Group Company Detail
- Table 51. Getinge Group Business Overview
- Table 52. Getinge Group Coronary Artery Bypass Grafts (CABG) Product
- Table 53. Getinge Group Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 54. Getinge Group Recent Development
- Table 55. LivaNova Company Detail
- Table 56. LivaNova Business Overview
- Table 57. LivaNova Coronary Artery Bypass Grafts (CABG) Product
- Table 58. LivaNova Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 59. LivaNova Recent Development
- Table 60. Terumo Company Detail
- Table 61. Terumo Business Overview
- Table 62. Terumo Coronary Artery Bypass Grafts (CABG) Product
- Table 63. Terumo Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 64. Terumo Recent Development
- Table 65. Boston Scientific Company Detail
- Table 66. Boston Scientific Business Overview
- Table 67. Boston Scientific Coronary Artery Bypass Grafts (CABG) Product
- Table 68. Boston Scientific Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 69. Boston Scientific Recent Development
- Table 70. Stryker Company Detail
- Table 71. Stryker Business Overview
- Table 72. Stryker Coronary Artery Bypass Grafts (CABG) Product
- Table 73. Stryker Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 74. Stryker Recent Development
- Table 75. Edwards Lifesciences Company Detail
- Table 76. Edwards Lifesciences Business Overview
- Table 77. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Product
- Table 78. Edwards Lifesciences Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 79. Edwards Lifesciences Recent Development
- Table 80. Genesee Biomedical Company Detail
- Table 81. Genesee Biomedical Business Overview
- Table 82. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Product
- Table 83. Genesee Biomedical Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 84. Genesee Biomedical Recent Development
- Table 85. Karl Storz GmbH Company Detail
- Table 86. Karl Storz GmbH Business Overview
- Table 87. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Product
- Table 88. Karl Storz GmbH Revenue in Coronary Artery Bypass Grafts (CABG) Business (2017-2022) & (US$ Million)
- Table 89. Karl Storz GmbH Recent Development
- Table 90. Medtronic Company Information
- Table 91. Medtronic Business Overview
- Table 92. Medtronic Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 93. Medtronic Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 94. Medtronic Recent Development
- Table 95. Getinge Group Company Information
- Table 96. Getinge Group Business Overview
- Table 97. Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 98. Getinge Group Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 99. Getinge Group Recent Development
- Table 100. LivaNova Company Information
- Table 101. LivaNova Business Overview
- Table 102. LivaNova Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 103. LivaNova Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 104. LivaNova Recent Development
- Table 105. Terumo Company Information
- Table 106. Terumo Business Overview
- Table 107. Terumo Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 108. Terumo Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 109. Terumo Recent Development
- Table 110. Boston Scientific Company Information
- Table 111. Boston Scientific Business Overview
- Table 112. Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 113. Boston Scientific Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 114. Boston Scientific Recent Development
- Table 115. Stryker Company Information
- Table 116. Stryker Business Overview
- Table 117. Stryker Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 118. Stryker Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 119. Stryker Recent Development
- Table 120. Edwards Lifesciences Company Information
- Table 121. Edwards Lifesciences Business Overview
- Table 122. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 123. Edwards Lifesciences Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 124. Edwards Lifesciences Recent Development
- Table 125. Genesee Biomedical Company Information
- Table 126. Genesee Biomedical Business Overview
- Table 127. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 128. Genesee Biomedical Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
- Table 129. Genesee Biomedical Recent Development
- Table 130. Karl Storz GmbH Company Information
- Table 131. Karl Storz GmbH Business Overview
- Table 132. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million)
- Table 133. Karl Storz GmbH Revenue in Coronary Artery Bypass Grafts (CABG) Business (2019-2024) & (US$ Million) Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.